Ann Surg Case Rep. 2023;6(4):1080. | Case Report | Open Access
Abstract | Fulltext PDF
Madhumita M, Malabika B, Subhamoy S, Rituparna K, Binata B and Chhanda D
Ann Surg Case Rep. 2023;6(3):1078. | Research Article | Open Access
Abstract | Fulltext PDF
Ana Belen L, Aldana Belen I, Mercedes Ines CG, Gonzalo C, Lucia B and Oggero AS
Ann Surg Case Rep. 2023;6(3):1077. | Case Report | Open Access
Abstract | Fulltext PDF
Madhumita M, Ananya G, Subhamoy S, Chhanda D, Binata B, Malabika B and Bidisha GN
Ann Surg Case Rep. 2023;6(3):1076. | Case Report | Open Access
Abstract | Fulltext PDF
Al-Mazrou AM, Basheer ON and Omer SN
Ann Surg Case Rep. 2023;6(3):1075. | Case Report | Open Access
Abstract | Fulltext PDF
Mohit S
Ann Surg Case Rep. 2023;6(2):1074. | Case Report | Open Access
Abstract | Fulltext PDF
Musa G, Ndandja DTK, Midov MZ, Hovrin DV, Chmutin GE and Slabov MV
Ann Surg Case Rep. 2023;6(2):1073. | Case Report | Open Access
Abstract | Fulltext PDF
Shi Y, Song L and Luo Y
Ann Surg Case Rep. 2023;6(2):1072. | Case Report | Open Access
Abstract | Fulltext PDF
Infanger C, Fadinger N, Ndarugendamwo A, Faoro D, Montani M and Mueller
Ann Surg Case Rep. 2023;6(2):1071. | Case Report | Open Access
Abstract | Fulltext PDF
Jude ST
Ann Surg Case Rep. 2023;6(2):1070. | Case Report | Open Access
Abstract | Fulltext PDF
Mosavari H, Farahani S and Saberi A
Ann Surg Case Rep. 2023;6(1):1069. | Case Report | Open Access
Abstract | Fulltext PDF
Aim: Percutaneous Balloon Aortic Valvuloplasty (BAV) is actually recommended as a bridge to surgery or transcatheter aortic valve replacement in patients with severe Aortic Stenosis (AS) in particular clinical settings. In this study, we compared the two years mortality of 50 patients (mean age 86.8 ± 4.68 years) with symptomatic AS undergoing BAV which does not require rapid ventricular pacing, with the mortality tables provided from the Italian National Institute of Statistics (ISTAT) in a period between 2019 and 2021. Methods and Results: At a median of 25 months, 36% patients died. The median time between BAV and mortality was 11 months. The independent predictors of mortality were the NYHA class at admission and STS score. (p<0.01 for both). From the comparison between the percentages of our data and the prospective probability of survival calculated by ISTAT for the whole population of the Marche region and whole Italian territory the survival rates were higher in the population undergoing BAV than in the control population for the age groups of 85 to 89 and 90 to 94. Conclusion: Our data showed a higher long-term survival rate for the symptomatic patients with severe AS treated with BAV, in comparison with the prospective probability of survival calculated by ISTAT in the 2019, 2020 and 2021 for the age groups of 85 to 89 and 90 to 94 both in the Marche region and the whole Italian territory. Our encouraging results should be confirmed from larger future study.
Ann Surg Case Rep. 2023;6(1):1068. | Case Report | Open Access
Abstract | Fulltext PDF
Baawain S and Aladawi RD
Ann Surg Case Rep. 2023;6(1):1067. | Case Report | Open Access
Abstract | Fulltext PDF
Pérez-Sáncheza I, Ausina-Gómeza S, Izquierdo-Plazasa L and Cerrolaza-Uristoa N
Ann Surg Case Rep. 2023;6(1):066.. | Case Report | Open Access
Abstract | Fulltext PDF
Deshkar S
Ann Surg Case Rep. 2023;6(1):1065. | Case Report | Open Access
Abstract | Fulltext PDF
Nikhilesh A